FBT Stock Overview
First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund is an exchange traded fund launched and managed by First Trust Advisors LP.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$148.20 |
52 Week High | US$161.41 |
52 Week Low | US$130.27 |
Beta | 0.69 |
1 Month Change | -2.49% |
3 Month Change | -0.37% |
1 Year Change | -4.53% |
3 Year Change | -8.43% |
5 Year Change | 10.68% |
Change since IPO | 643.23% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
FBT | US Capital Markets | US Market | |
---|---|---|---|
7D | 3.2% | 0.2% | 0.7% |
1Y | -4.5% | 33.2% | 23.9% |
Return vs Industry: FBT underperformed the US Capital Markets industry which returned 35% over the past year.
Return vs Market: FBT underperformed the US Market which returned 24.2% over the past year.
Price Volatility
FBT volatility | |
---|---|
FBT Average Weekly Movement | 2.5% |
Capital Markets Industry Average Movement | 3.5% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FBT has not had significant price volatility in the past 3 months.
Volatility Over Time: FBT's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | n/a | www.ftportfolios.com/Retail/etf/etfsummary.aspx?Ticker=FBT |
First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund is an exchange traded fund launched and managed by First Trust Advisors LP. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors.
First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund Fundamentals Summary
FBT fundamental statistics | |
---|---|
Market cap | US$1.11b |
Earnings (TTM) | US$20.93m |
Revenue (TTM) | US$3.48m |
53.5x
P/E Ratio321.9x
P/S RatioIs FBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FBT income statement (TTM) | |
---|---|
Revenue | US$3.48m |
Cost of Revenue | US$0 |
Gross Profit | US$3.48m |
Other Expenses | -US$17.46m |
Earnings | US$20.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 2.77 |
Gross Margin | 100.00% |
Net Profit Margin | 602.15% |
Debt/Equity Ratio | 0.1% |
How did FBT perform over the long term?
See historical performance and comparison